Fast track for LymphoStat B for SLE

Thread view:

Enable EMail Alerts

Start New Thread

Thread rating:

blader - 16 Apr 2004 08:26 GMT

http://www.hgsi.com/products/LSB.html

"LymphoStat-B has received a Fast Track Product designation from the
U.S. Food and Drug Administration (FDA) for the treatment of systemic
lupus erythematosus. For a new drug to be designated a Fast Track
Product, the condition it is designed to treat must be serious or
life-threatening, and must represent an unmet medical need."

It is in Phase II clinical trial at NIH for SLE and rheumatoid arthritis.

Bruce

Reply to this Message

RhondaM - 15 Apr 2004 21:21 GMT

There is hope there...
Wonder how much it will cost and if it will be less expensive than Remacade.
Very interesting

> http://www.hgsi.com/products/LSB.html
>
[quoted text clipped - 7 lines]
>
> Bruce

Reply to this Message

blader - 16 Apr 2004 09:57 GMT

AS LymphoStat B is a "biological" medication, the cost is probably high,
perhaps as much as Remicade or even more.

However, I think that people enrolled in NIH clinical trials may have
their drugs paid for by the NIH.. I don't know that for a fact though.

Bruce

Reply to this Message